Author:
Tsareva E. Yu.,Favorova O. O.,Boyko A. N.,Kulakova O. G.
Subject
Structural Biology,Biophysics
Reference118 articles.
1. Kalow W. 2002. Pharmacogenetics and personalised medicine. Fundam. Clin. Pharmacol. 16, 337–342.
2. Seredenin S.B. 2004. Lectures in Pharmacogenetics. Moscow: MIA.
3. Stepanov V.A. 2010. Genomes, populations, diseases: Ethnic genomics and personilized medicine. Acta Nature. 4, 18–34.
4. Laing R.E., Hess P., Shen Y., Wang J., Hu S.X. 2011. The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr. Drug. Metab. 12, 460–486.
5. Sauna Z.E., Kimchi-Sarfaty C., Ambudkar S.V., Gottesman M.M. 2007. Silent polymorphisms speak: How they affect pharmacogenomics and the treatment of cancer. Cancer Res. 67, 9609–9612.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Literatur;Multiple Sklerose;2022